Identification of Smac mimetics as novel substrates for p-glycoprotein

Manuela Hugle1, Sebastian Czaplinski1, Karoline Habermann1

  • 1Institute for Experimental Cancer Research in Pediatrics, Goethe-University, Komturstrasse 3a, 60528, Frankfurt, Germany.

Cancer Letters
|October 13, 2018
PubMed

Insights

Multidrug resistance (MDR) in pediatric cancer involves p-glycoprotein, which exports drugs. This study found Smac mimetics are also exported by p-glycoprotein, suggesting new therapeutic strategies.

Area of Science:

  • Oncology
  • Cancer Biology
  • Pharmacology

Background:

  • Multidrug resistance (MDR) hinders chemotherapy effectiveness in various cancers, including pediatric tumors.
  • High p-glycoprotein expression in cancer cells often drives MDR by exporting chemotherapeutic drugs.
  • Pediatric cancer cells were studied to understand acquired resistance mechanisms.

Purpose of the Study:

  • To investigate the role of p-glycoprotein in acquired chemoresistance in pediatric cancer cells.
  • To determine if novel therapeutics, Smac mimetics, are affected by p-glycoprotein-mediated MDR.
  • To explore potential therapeutic strategies combining Smac mimetics with p-glycoprotein inhibitors.

Main Methods:

  • Generation of pediatric cancer cells with acquired resistance to vincristine (VCR).
  • Assessment of p-glycoprotein expression levels in VCR-resistant cells.
  • Testing cross-resistance profiles of VCR-resistant cells against various chemotherapeutics and Smac mimetics.
  • Evaluating the effect of p-glycoprotein inhibitors on Smac mimetic sensitivity.

Main Results:

  • Vincristine-resistant pediatric cancer cells exhibited increased p-glycoprotein expression and a multidrug-resistant phenotype.
  • These cells showed cross-resistance to doxorubicin and etoposide, consistent with MDR.
  • Notably, VCR-resistant cells displayed cross-resistance to several Smac mimetics.
  • Resistance to Smac mimetics was reversed by p-glycoprotein inhibitors, indicating Smac mimetics are p-glycoprotein substrates.

Conclusions:

  • P-glycoprotein mediates resistance to Smac mimetics in pediatric cancer cells.
  • Smac mimetics are identified as novel substrates for p-glycoprotein.
  • Findings may inform clinical trial design, suggesting combinations of Smac mimetics with p-glycoprotein inhibitors to overcome MDR.

Related Concept Videos

Matrix Proteoglycans and Glycoproteins01:21

Matrix Proteoglycans and Glycoproteins

Proteoglycans are extensively glycosylated proteins, commonly found in the extracellular matrix, interwoven with collagen fibers. Hyaline cartilage, the most common type of cartilage in the body, consists of short and dispersed collagen fibers associated with large amounts of proteoglycans. These proteoglycans have long negative charges that attract cations, which in turn attract water molecules. This influx of ions and water molecules swells up the proteoglycan like a water-soaked gel that can...
5.1K
Methods of Classification and Identification01:28

Methods of Classification and Identification

Bacterial identification relies on a diverse array of techniques to classify and understand microorganisms, each tailored to uncover specific characteristics. Traditional morphological approaches, while still valuable, are limited for closely related or structurally simple organisms. Modern methods integrate biochemical, serological, genetic, and advanced molecular tools to achieve greater accuracy.Morphological and Biochemical TechniquesMorphological characteristics, such as cell shape and...
1.2K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.3K
Peptide Identification Using Tandem Mass Spectrometry01:33

Peptide Identification Using Tandem Mass Spectrometry

Tandem mass spectrometry, also known as MS/MS or MS2, is an analytical technique that employs two mass analyzers. Essentially it is a series of mass spectrometers that helps isolate a particular biomolecule and then helps study its chemical properties.
This technique helps gather information regarding the protein from which the peptide was obtained and to study the peptides’ amino acid sequence. Identifying peptides from a complex mixture is an important component of the growing field of...
8.4K
Conjugated Proteins02:50

Conjugated Proteins

Simple proteins and protein complexes contain only amino acids. In contrast, many other proteins, called conjugated proteins, covalently bond with non-protein moieties.
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
28.7K
The Fluid Mosaic Model01:34

The Fluid Mosaic Model

The fluid mosaic model was first proposed as a visual representation of research observations. The model comprises the composition and dynamics of membranes and serves as a foundation for future membrane-related studies. The model depicts the structure of the plasma membrane with a variety of components, which include phospholipids, proteins, and carbohydrates. These integral molecules are loosely bound, defining the cell’s border and providing fluidity for optimal function.
178.1K